Pfizer to Acquire Trillium Therapeutics Inc. Business Wire - 23 Aug 2021 Pfizer to Acquire Trillium Therapeutics Inc. ... More
Trillium Therapeutics' stock nearly triples after buyout deal with Pfizer valued at $2.26 billion MarketWatch - 23 Aug 2021 Trillium Therapeutics' stock nearly triples after buyout deal with Pfizer valued at $2.26 billion ... More
Trillium Therapeutics Announces $25 Million Equity Investment From Pfizer Inc. GlobeNewswire - 08 Sep 2020 Trillium Therapeutics Announces $25 Million Equity Investment From Pfizer Inc. ... More
Pfizer to acquire Trillium in $2.3bn deal BioProcess International - 03 Mar 2024 Pfizer to acquire Trillium in $2.3bn deal ... More
Pfizer to buy cancer drug developer Trillium in $2.3 bln deal Reuters - 23 Aug 2021 Pfizer to buy cancer drug developer Trillium in $2.3 bln deal ... More
UPDATE: Pfizer and Trillium: How a $25M investment led to a $2.3B buyout Fierce Biotech - 14 Sep 2021 UPDATE: Pfizer and Trillium: How a $25M investment led to a $2.3B buyout ... More
Cancer Drug Bet Pays Off for Biotech CEO With 3,600% Stock Surge Bloomberg.com - 30 Sep 2020 Cancer Drug Bet Pays Off for Biotech CEO With 3,600% Stock Surge ... More
Did You Miss Out on a 5000% Gain With Trillium Stock? Nasdaq - 08 Dec 2020 Did You Miss Out on a 5000% Gain With Trillium Stock? ... More
Pfizer bets on CD47 blockade in cancer with $2.3B Trillium bid BioWorld MedTech - 23 Aug 2021 Pfizer bets on CD47 blockade in cancer with $2.3B Trillium bid ... More
Pfizer acquires immuno-oncology firm Trillium for $2.22bn Pharmaceutical Technology - 18 Nov 2021 Pfizer acquires immuno-oncology firm Trillium for $2.22bn ... More
Pfizer to buy Canadian ‘blockbuster’ cancer drug developer Trillium Therapeutics in $2.26-billion deal The Globe and Mail - 23 Aug 2021 Pfizer to buy Canadian ‘blockbuster’ cancer drug developer Trillium Therapeutics in $2.26-billion deal ... More
Jan Skvarka, former Trillium CEO, on Driving a Turnaround Timmerman Report - 30 Mar 2023 Jan Skvarka, former Trillium CEO, on Driving a Turnaround ... More
Pfizer stocks cancer drug pipeline with $2.3B deal for Trillium BioPharma Dive - 23 Aug 2021 Pfizer stocks cancer drug pipeline with $2.3B deal for Trillium ... More
Small-Cap Biotech Stocks Soar on Coronavirus Speculation Investopedia - 02 Mar 2020 Small-Cap Biotech Stocks Soar on Coronavirus Speculation ... More
Pfizer swallows CD47 biotech Trillium in $2.3B takeover Fierce Biotech - 23 Aug 2021 Pfizer swallows CD47 biotech Trillium in $2.3B takeover ... More
This Biotech Stock Is Too Cheap to Ignore Nasdaq - 29 Jul 2021 This Biotech Stock Is Too Cheap to Ignore ... More
Pfizer bets on Arena's promising bowel disease treatment in $6.7 bln deal Reuters - 13 Dec 2021 Pfizer bets on Arena's promising bowel disease treatment in $6.7 bln deal ... More
Trillium Therapeutics Appoints Jan Skvarka as President and Chief Executive Officer GlobeNewswire - 25 Sep 2019 Trillium Therapeutics Appoints Jan Skvarka as President and Chief Executive Officer ... More
Trillium Announces Pricing of US$15 Million Public Offering GlobeNewswire - 22 Feb 2019 Trillium Announces Pricing of US$15 Million Public Offering ... More